Abbott, AbbVie Pay $25M Over Off-Label Promos, Kickbacks
Abbott Laboratories and AbbVie Inc. will fork over $25 million to end a whistleblower's False Claims Act case alleging off-label promotion of triglyceride drug TriCor and unlawful kickbacks in the form...To view the full article, register now.
Already a subscriber? Click here to view full article